Global Antibiotic Resistance Market, By Disease Type (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections and Others), Pathogen Type (Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, Streptococcus Pneumoniae and Others) Drugs Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines and Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
The antibiotic resistance market is expected to witness market growth at a rate of 4.35% in the forecast period of 2021 to 2028. Data Bridge Market Research report on antibiotic resistance market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the cases of indoor as well as outdoor infections is escalating the growth of antibiotic resistance market.
Antibiotics can be referred as the medications that are broadly utilized for the treatment of several forms of infections. Antibiotics resistance develops when infections stop reacting to the current antibiotics.
Major factors that are expected to boost the growth of the antibiotic resistance market in the forecast period are the rise in the incidence rate of infectious diseases around the world. Furthermore, the developments in the nutrition, antibiotics and immunization is further anticipated to propel the growth of the antibiotic resistance market. On the other hand, the efficient treatment is either unaffordable or unavailable is further projected to impede the growth of antibiotic resistance market in the timeline period.
In addition, the accelerate need of novel therapies will further provide potential opportunities for the growth of the antibiotic resistance market in the coming years. However, the dearth of trained personnel and strict safety guidelines might further challenge the growth of the antibiotic resistance market in the near future.
The antibiotic resistance market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the antibiotic resistance market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Antibiotic Resistance Market Scope and Market Size
The antibiotic resistance market is segmented on the basis of disease type, pathogen type, drugs class and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of disease type, the antibiotic resistance market is segmented into urinary tract infection, intra-abdominal infections, blood stream infections, clostridium difficile infections and others.
- On the basis of pathogen type, the antibiotic resistance market is segmented into acinetobacter baumannii, pseudomonas aeruginosa, staphylococcus aureus, streptococcus pneumoniae and others.
- On the basis of drugs class, the antibiotic resistance market is segmented into oxazolidinones, lipoglycopeptides, tetracyclines and others.
- On the basis of end users, the antibiotic resistance market is segmented into hospitals, homecare, specialty clinics, others.
Antibiotic Resistance Market Country Level Analysis
The antibiotic resistance market is analysed and market size information is provided by country, disease type, pathogen type, drugs class and end users as referenced above.
The countries covered in the antibiotic resistance market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the antibiotic resistance market due to the various drug launches in the market. Furthermore, the rise in the treatment cost will further boost the growth in the antibiotic resistance market in the region during the forecast period. Europe is projected to observe significant amount of growth of the antibiotic resistance market due to the antibiotic resistance market due to the rise in the number of antibiotic-resistant infections. Moreover, the increase in the healthcare facilities is further anticipated to propel the growth of the antibiotic resistance market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The antibiotic resistance market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Antibiotic Resistance Market Share Analysis
The antibiotic resistance market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to antibiotic resistance market.
The major players covered in the antibiotic resistance market report are Achaogen, Inc., Nabriva Therapeutics plc, BioVersys AG, Johnson & Johnson Services, Inc, Destiny Pharma plc, Armata Pharmaceuticals, Inc, Westway Health, NEMESIS BIOSCIENCE LTD, Tetraphase Pharmaceuticals, The Medicines Company, ALLERGAN, Merck & Co., Inc., Pfizer Inc, CARB-X, MELINTA THERAPEUTICS, INC, Novartis AG, Vertex Pharmaceuticals Incorporated, GlaxoSmithKline Plc, AbbVie Inc and F. Hoffmann-La Roche Ltd among other domestic and global players. The antibiotic resistance market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.